Reshape Biotech raised €18M in a Series A round in Apr 2024. The company is based in Copenhagen, Denmark. Investors in the round: 21stBio, ACME Capital, Astanor Ventures and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
